Dore Rhys, Chang Chu-Ting, Declève Amber, Brunori Gloria, Ludlam W Grant, Huang Alden, Movahedinia Mojtaba, Damseh Nadirah S, Anwar Ijaz, Vahidi Mehrjardi Mohammad Yahya, Ny Annelii, Khorrami Mehdi, Kheirollahi Majid, Frederiksen Helen, Eghbal Fatemeh, Mirjalili Mohammad Reza, Dehghani Mohammadreza, Karimiani Ehsan Ghayoor, Oreshkov Sergey, Alves Cesar, Striano Pasquale, Suri Mohnish, Martinez-Agosto Julian, Ansar Muhammad, Zahid Muhammad, Akram Samra, Ansar Muhammad, Nelson Stanley F, Antonarakis Stylianos E, Houlden Henry, Copmans Daniëlle, Martemyanov Kirill A, Maroofian Reza
Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom; Department of Clinical Genetics, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Department of Neuroscience, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology and Skaggs Graduate School, The Scripps Research Institute, Jupiter, Florida, United States.
Genet Med. 2025 Jun 23:101506. doi: 10.1016/j.gim.2025.101506.
Synaptic communication deficits are central to many neurodevelopmental disorders. However, for rare monogenic conditions, these disorders remain poorly defined, with limited understanding of their molecular etiology. A homozygous frameshift variant in the synaptic cell adhesion molecule ELFN1 was reported in a family with three affected siblings with epileptic encephalopathy, alongside a missense variant of uncertain significance in a cohort study involving a family with intellectual disability. Therefore, we sought to evaluate the role and mechanism of biallelic ELFN1 variants in disease pathogenesis.
We describe eight newly identified individuals from five unrelated families, all carrying homozygous ELFN1 variants, including frameshift and in-frame deletions. By integrating data from these cases with clinical details from six previously reported individuals, we delineate the phenotypic spectrum associated with ELFN1 variants.
Clinical features include varying degrees of developmental delay/intellectual disability, epilepsy, and movement disorders. Molecular investigations reveal that these variants disrupt ELFN1 protein trafficking to the cell surface, resulting in loss of function. Functional modeling in mice and zebrafish demonstrates the role of Elfn1 loss in motor activity abnormalities and seizures.
Our findings establish ELFN1 deficiency as the cause of a distinct, rare neurodevelopmental disorder, providing a foundation for future investigations into its pathophysiology and therapeutic strategies.
突触通讯缺陷是许多神经发育障碍的核心问题。然而,对于罕见的单基因疾病,这些障碍的定义仍不明确,对其分子病因的了解有限。在一个有三名患癫痫性脑病的患病兄弟姐妹的家庭中,报道了突触细胞粘附分子ELFN1中的一个纯合移码变异,同时在一项涉及一个智障家庭的队列研究中发现了一个意义不确定的错义变异。因此,我们试图评估双等位基因ELFN1变异在疾病发病机制中的作用和机制。
我们描述了来自五个无关家庭的八名新确诊个体,他们均携带ELFN1纯合变异,包括移码和框内缺失。通过将这些病例的数据与之前报道的六名个体的临床细节相结合,我们描绘了与ELFN1变异相关的表型谱。
临床特征包括不同程度的发育迟缓/智力残疾、癫痫和运动障碍。分子研究表明,这些变异破坏了ELFN1蛋白向细胞表面的运输,导致功能丧失。在小鼠和斑马鱼中的功能建模证明了Elfn1缺失在运动活动异常和癫痫发作中的作用。
我们的研究结果确定ELFN1缺乏是一种独特的、罕见的神经发育障碍的病因,为未来对其病理生理学和治疗策略的研究奠定了基础。